Journal of Psychosomatic Research
Volume 62, Issue 1 , Pages 61-72 , January 2007

MMPI-2 validity, clinical and content scales, and the Fake Bad Scale for personal injury litigants claiming idiopathic environmental intolerance

  • Herman Staudenmayer

      Affiliations

    • Behavioral Medicine Clinic, Denver, CO, USA
    • Corresponding Author InformationCorresponding. Behavioral Medicine Clinic, Denver, CO 80222, USA.
    • ,
  • Scott Phillips

      Affiliations

    • University of Colorado Health Sciences Center, Denver, CO, USA
    • NewFields, Denver, CO, USA

Received 25 April 2005

References 

  1. International Programme on Chemical Safety/World Health Organization (IPCS/WHO) . Conclusions and recommendations of a workshop on multiple chemical sensitivities (MCS). Regul Toxicol Pharmacol. 1996;24:S188–S189
  2. Cullen MR. The worker with multiple chemical sensitivities: an overview. Occup Med. 1987;2:655–662
  3. Caccappolo-van Vliet E, Kelly-McNeil K, Natelson B, Kipen H, Fiedler N. Anxiety sensitivity and depression in multiple chemical sensitivities and asthma. J Occup Environ Med. 2002;44:890–901
  4. Staudenmayer H, Binkley KE, Leznoff A, Phillips S. Idiopathic Environmental Intolerance: Part 1. A causation analysis applying Bradford Hill's criteria to the toxicogenic theory. Toxicol Rev. 2003;22:235–246
  5. Staudenmayer H, Binkley KE, Leznoff A, Phillips S. Idiopathic Environmental Intolerance: Part 2. A causation analysis applying Bradford Hill's criteria to the psychogenic theory. Toxicol Rev. 2003;22:247–261
  6. American Academy of Allergy Asthma and Immunology . Board of Directors Position statement: Idiopathic Environmental Intolerances. J Allergy Clin Immunol. 1999;103:36–40
  7. American College of Occupational and Environmental Medicine . Multiple chemical sensitivities: idiopathic environmental intolerance. Position statement. ACOEM Rep. 1999;1–3
  8. American Academy of Clinical Toxicology, Board of Trustees minutes, March 29, 2000.
  9. Rea WJ. Chemical sensitivity: vol. 1. Principles and mechanisms. Boca Raton (Fla): Lewis Publishers/CRC Press; 1992;
  10. Ashford NA, Miller CS. Chemical exposures: low levels and high stakes. 2nd ed. New York: Van Nostrand Reinhold; 1998;
  11. American Medical Association . Council on Scientific Affairs Report: clinical ecology. JAMA. 1992;268:3465–3467
  12. American College of Physicians . Position paper: clinical ecology. Ann Intern Med. 1989;111:168–178
  13. Royal College of Physicians . Allergy, conventional and alternative concepts. Report by the Committee on Clinical Immunology and Allergy. London: Royal College of Physicians; 1992;
  14. International Society of Regulatory Toxicology and Pharmacology (ISRTP). Report of the Board. Regul Toxicol Pharmacol. 1993;18:79
  15. Hammond EC. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health. 1964;54:11–23
  16. Eriksen HR, Ursin H. Subjective health complaints, sensitization, and sustained cognitive activation (stress). J Psychosom Res. 2004;56:445–448
  17. Hausteiner C, Bornschein S, Bickel H, et al. Psychiatric morbidity and low self-attentiveness in patients with environmental illness. J Nerv Ment Dis. 2003;191:50–55
  18. Simon GE, VonKorff M, Piccinelli M, et al. An international study of the relation between somatic symptoms and depression. N Engl J Med. 1999;341:1329–1335
  19. Simon DE, Daniell W, Stockbridge H, Claypoole K, Rosenstock L. Immunologic, psychological, and neuropsychological factors in multiple chemical sensitivity: a controlled study. Ann Intern Med. 1993;19:97–103
  20. Bolla KI. Neurobehavioral performance in multiple chemical sensitivities. Regul Toxicol Pharmacol. 1996;24:S52–S54
  21. Fiedler N, Kipen H, DeLuca J, Kelly-McNeil K, Natelson B. A controlled comparison of multiple chemical sensitivity and chronic fatigue syndrome. Psychosom Med. 1996;58:38–49
  22. Brown-DeGagne AM, McGlone J, Santor DA. Somatic complaints disproportionately contribute to Beck Depression Inventory estimates of depression severity in individuals with multiple chemical sensitivity. J Occup Environ Med. 1998;40:862–869
  23. Bolla KI. Use of neuropsychological testing in idiopathic environmental intolerance. Occup Med. 2000;15:617–625
  24. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialties. J Psychosom Res. 2001;51:361–367
  25. Staudenmayer H. Psychological treatment of psychogenic idiopathic environmental intolerance. Occup Med. 2000;15:627–646
  26. Bornschein S, Forstl H, Zilker T. Idiopathic Environmental Intolerances (formerly multiple chemical sensitivity) psychiatric perspectives. J Intern Med. 2001;250:309–321
  27. Ford CV. Somatization and fashionable diagnoses: illness as a way of life. Scan J Work Environ Health. 1997;23(Suppl 3):7–16
  28. Barsky AJ, Borus JF. Somatization and medicalization in the era of managed care. JAMA. 1995;274:1931–1934
  29. Shorter E. From paralysis to fatigue: a history of psychosomatic illness in the modern era. New York: Free Press/Macmillan; 1992;
  30. Shorter E. Multiple chemical sensitivity: pseudodisease in historical perspective. Scand J Work Environ Health. 1997;23(Suppl 3):35–42
  31. Staudenmayer H. Environmental illness: myth and reality. Boca Raton: CRC/Lewis Publishers; 1999;
  32. Staudenmayer H. Idiopathic Environmental Intolerances (IEI): myth and reality. Toxicol Lett. 2001;120:333–342
  33. Hathaway SR, McKinley JC. A multiphasic personality schedule (Minnesota): 1. Construction of the schedule. J Psychol. 1940;10:249–254
  34. Butcher JN, Dahlstrom WG, Graham JR, et al. Minnesota Multiphasic Personality Inventory (MMPI-2). Minneapolis (Minn): University of Minnesota Press; 1989;
  35. Pope K, Butcher J, Seelen J. The MMPI, MMPI-2, & MMPI-A in court. 2nd ed. Washington (DC): American Psychological Association; 2000;
  36. Graham JR. MMPI-2 Assessing personality and psychopathology. 3rd ed. New York: Oxford University Press; 2000;
  37. Butcher JN, Williams CL. Essentials of MMPI-2 and MMPI-A interpretation. 2nd ed. Minneapolis: University of Minnesota Press; 2000;
  38. Lees-Haley PR, Iverson GL, Lange RT, Fox DD, Allen LM. Malingering in forensic neuropsychology: Daubert and the MMPI-2. J Forensic Neuropsychol. 2003;3:167–203
  39. Lees-Haley PR, English LT, Glenn WJ. A fake bad scale on the MMPI-2 for personal injury claimants. Psychol Rep. 1991;68:203–210
  40. Lees-Haley PR. Efficacy of MMPI-2 validity scales and MCMI-II modifier scales for detecting spurious PTSD claims: F, F-K, Fake Bad Scale, Ego Strength, subtle-obvious subscales, DIS and DEB. J Clin Psychol. 1992;48:681–689
  41. Greiffenstein MF, Baker WJ, Axelrod B, Peck EA, Gervais R. The Fake Bad Scale and MMPI-2 F-family in detection of implausible psychological trauma claims. Clin Neuropsychol. 2004;18:573–590
  42. Posthuma AB, Harper JF. Comparison of MMPI-2 responses of child custody and personal injury litigants. Prof Psychol Res Pract. 1998;29:437–443
  43. Tsushima WT, Tsushima VG. Comparison of the Fake Bad Scale and other MMPI-2 validity scales with personal injury litigants. Assessment. 2001;8:205–212
  44. Greiffenstein MF, Baker WJ, Gola T, Donders J, Miller L. The Fake Bad Scale in atypical and severe closed head injury litigants. J Clin Psychol. 2002;58:1591–1600
  45. Ross SR, Millis SR, Krukowski RA, Putnam SH, Adams KM. Detecting incomplete effort on the MMPI-2: an examination of the Fake-Bad Scale in mild head injury. J Clin Exp Neuropsychol. 2004;26:115–124
  46. Larrabee GJ. Exaggerated MMPI-2 symptom report in personal injury litigants with malingered neurocognitive deficit. Arch Clin Neuropsychol. 2003;18:673–686
  47. Larrabee GJ. Detection of symptom exaggeration with the MMPI-2 in litigants with malingered neurocognitive dysfunction. Clin Neuropsychol. 2003;17:54–68
  48. Larrabee GJ. Detection of malingering using atypical performance patterns on standard neuropsychological tests. Clin Neuropsychol. 2003;17:410–425
  49. Nelson NW, Sweet JJ, Demakis GJ. Meta-analysis of the MMPI-2 Fake Bad Scale: utility in forensic practice. Clin Neuropsychol. 2006;20:39–58
  50. Butcher JN, Graham JR, Ben-Porath YS, et al. MMPI-2 (Minnesota Multiphasic Personality Inventory-2): manual for administration and scoring. Minneapolis: University of Minnesota Press; 2001;
  51. Arbisi PA, Ben-Porath YS. An MMPI-2 infrequency response scale for use with psychopathological populations: the Infrequency Psychopathology Scale, FP. Psychol Assess. 1995;7:424–431
  52. Greene RL. Assessment of malingering and defensiveness on multiscale inventories. In:  Rogers R editors. Clinical assessment of malingering and deception. 2nd ed. New York: Guilford Press; 1997;p. 169–207
  53. Lees-Haley P. MMPI-2 base rates for 492 personal injury plaintiffs: implications and challenges for forensic assessment. J Clin Psychol. 1997;53:745–755
  54. Lanyon RI. Dimensions of self-serving misrepresentation in forensic assessment. J Pers Assess. 2001;76:169–179
  55. Leavitt F, Katz RS. Is the MMPI invalid for assessing psychological disturbance in pain related organic conditions?. J Rheumatol. 1989;16:521–526
  56. Keller LS, Butcher JN. Use of the MMPI-2 with chronic pain patients. Minneapolis: University of Minnesota Press; 1991;
  57. Winfield JB. Pain in fibromyalgia. Rheumatol Clin North Am. 1999;25:55–79
  58. Payne TC, Leavitt F, Garron DC, et al. Fibrositis and psychologic disturbance. Arthritis Rheum. 1982;25:213–217
  59. Ahles TA, Yunus MB, Riley SD, et al. Psychological factors associated with primary fibromyalgia syndrome. Arthritis Rheum. 1984;27:1101–1106
  60. Wolfe F, Cathey MA, Kleinheksel SM, et al. Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis. J Rheumatol. 1984;11:500–506
  61. Thompson WG. Symptomatic perceptions of the irritable bowel syndrome. Gastrointest Clin N Am. 1991;20:235–247
  62. Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome: a multivariate study of patients and non-patients with irritable bowel syndrome. Gastroenterology. 1988;95:701–708
  63. Blanchard EB, Keefer L, Galovski TE, et al. Gender differences in psychological distress among patients with irritable bowel syndrome. J Psychosom Res. 2001;50:271–275
  64. Holmes GP, Kaplan JE, Stewart JA, Hunt B, Pinsky PF, Schonberger LB. A cluster of patients with a chronic mononucleosis-like syndrome: is Epstein–Barr virus the cause?. JAMA. 1987;257:2297–2302
  65. Kruesi MJP, Dale J, Straus SE. Psychiatric diagnoses in patients who have chronic fatigue syndrome. J Clin Psychiatry. 1989;50:53–56
  66. Stricklin A, Sewell M, Austad C. Objective measurement of personality variables in epidemic neuromyasthenia patients. S Afr Med J. 1990;77:31–34
  67. Blakely AA, Howard RC, Sosich RM, Murdoch JC, Menkes DB, Spears GFS. Psychiatric symptoms, personality and ways of coping in chronic fatigue syndrome. Psychol Med. 1991;21:347–362
  68. Schmaling KB, Jones JF. MMPI profiles of patients with chronic fatigue syndrome. J Psychosom Res. 1996;40:67–74
  69. World Health Organization . Mental disorders: glossary and guide to their classification in accordance with the 9th revision of the International Classification of Diseases. Geneva: World Health Organization; 1978;
  70. American Academy of Neurology . Report of the Therapeutics and Technology Assessment Subcommittee: assessment of neuropsychological testing in adults. Neurology. 1996;47:592–599
  71. Binder LM, Willis SC. Assessment of motivation after financially compensable minor head trauma. Psychol Assess. 1991;3:175–181
  72. Binder LM, Rohling ML. Money matters: a meta-analytic review of the effects of financial incentives on recovery after closed head injury. Am J Psychiatry. 1996;153:7–10
  73. Youngjohn JR, Burrows L, Erdal K. Brain damage or compensation neurosis? The controversial post-concussion syndrome. Clin Neuropsychol. 1995;9:112–123
  74. Youngjohn JR, Davis D, Wolf I. Head injury and MMPI-2: paradoxical severity effects and the influence of litigation. Psychol Assess. 1997;9:177–184
  75. Deary IJ. A taxonomy of medically unexplained symptoms. J Psychosom Res. 1999;47:51–59
  76. Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M. How many functional somatic syndromes?. J Psychosom Res. 2001;51:549–557
  77. Wessely S. Chronic fatigue syndrome: a 20th century illness. Scand J Work Environ Health. 1997;23(Suppl 3):17–34
  78. Ursin H, Eriksen HR. The cognitive activation theory of stress. Psychoneuroendocrinology. 2004;29:567–592
  79. McKenna PJ. Disorders with overvalued ideas. Br J Psychiatry. 1984;145:579–585
  80. Hubert P. Galileo's revenge: junk science in the court room. New York: Basic Books; 1991;
  81. Terr AI. Environmental illness: a clinical review of 50 cases. Arch Intern Med. 1986;146:145

PII: S0022-3999(06)00039-0

doi: 10.1016/j.jpsychores.2006.01.013

Journal of Psychosomatic Research
Volume 62, Issue 1 , Pages 61-72 , January 2007

Article Tools